Alvox Bio
Alvox Bio31About
What does Alvox Bio do?
Alvox Bio develops and operates a proprietary platform integrating advanced human-derived 3D models, including bioprinted tissues and organoids, to generate biologically relevant preclinical data for drug discovery and translational research. Their fit-for-purpose models are designed for oncology, immune-enabled, and tissue-context applications, serving partners seeking decision-grade preclinical platforms.
Where is Alvox Bio headquartered?
Alvox Bio is headquartered in Cambridge, United States.
When was Alvox Bio founded?
Alvox Bio was founded in 2021.
What industry does Alvox Bio operate in?
Alvox Bio operates in Life Sciences, Biotech, Drug Discovery, Genomics, AI-Driven Protein Design, Therapeutic Antibodies.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
Biotalent is a platform that streamlines biotech hiring by connecting qualified candidates with job opportunities and providing hiring teams with tools for efficient candidate review.
AI-powered platform accelerating biological research and drug discovery.
A healthcare and life sciences consulting firm leveraging AI and data analytics for strategic solutions.
Empowering Life Science Entrepreneurs for Innovative Healthcare Solutions.
An entrant is a company tagged Life Sciences whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.